-- 三星电子(KRX:005930)第一季度营业利润飙升八倍,创历史新高,销售额也创下季度新高。 根据周四提交给韩国交易所的文件,三星电子第一季度营业利润飙升756%,达到57.2万亿韩元,较去年同期的6.69万亿韩元增长756%。 据CNBC报道,伦敦证券交易所集团(LSEG)的SmartEstimate此前预测三星电子第一季度营业利润为55.28万亿韩元。 这家韩国芯片制造商的销售额同比增长69%,达到133.9万亿韩元,创下季度历史新高,高于去年同期的79.14万亿韩元。 据CNBC报道,伦敦证券交易所集团(LSEG)的SmartEstimate此前预测三星电子第一季度营收将达到132.69万亿韩元。 三星电子周四发布的新闻稿显示,由于平均售价上涨,其设备解决方案部门的营业利润达到53.7万亿韩元,销售额环比增长86%至81.7万亿韩元。 该公司半导体部门的销售额也超出预期,这主要得益于满足了高附加值人工智能的需求。三星表示,行业内存价格的普遍上涨也推动了销售额的增长。 彭博社当天另行报道称,该半导体部门的业绩也超过了分析师平均预期的35.3万亿韩元。 设备体验部门的销售额增长了19%,这主要得益于三星新款旗舰智能手机的发布。 三星表示,尽管成本压力增加,但该领域的销售额仍然实现了增长。 显示器部门的营业利润达到4000亿韩元,合并收入达到6.7万亿韩元。 由于季节性因素和内存价格高企,其中小显示器业务的业绩有所下滑。 三星表示,移动业务(MX)利润增长至2.8万亿韩元,销售额跃升至38.1万亿韩元,这主要得益于“高端产品组合”。 三星电子预测,半导体业务将引领第二季度增长,尽管人工智能基础设施在截至6月的三个月内有所扩张,但存储器业务预计仍将保持强劲势头。 三星表示,随着人工智能和大型语言模型服务的日益普及,下半年存储器需求预计将保持强劲。 三星预计,到第二季度,先进节点生产线将全面投入使用。
Related Articles
Joinn Laboratories Grants 1.4 Million Award Shares Under 2022 Scheme
Joinn Laboratories (SHA:603127, HKG:6127) granted a little over 1.4 million award shares to 12 participants under a 2022 share incentive scheme, according to a Thursday Hong Kong bourse filing.Of the total, 500,00 shares were granted to Chair Feng Yuxia, with the others being offered to directors and managers of the group.
Sector Update: Financial Stocks Decline Pre-Bell Thursday
Financial stocks were declining pre-bell Thursday, with the State Street Financial Select Sector SPDR ETF (XLF) down 0.6%.The Direxion Daily Financial Bull 3X Shares (FAS) was 1.9% lower and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was up 1.9%.Banco Bilbao Vizcaya Argentaria (BBVA) stock was up more than 2% after the company reported higher Q1 adjusted earnings and gross income.ING Groep (ING) shares were up more than 2% after the company posted higher Q1 earnings and total income.Willis Towers Watson (WTW) stock was down more than 9% even after the company posted higher Q1 adjusted earnings and revenue.
Sector Update: Health Care Stocks Rise Premarket Thursday
Health care stocks were rising premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1% higher and the iShares Biotechnology ETF (IBB) up 0.6%.Eli Lilly (LLY) shares were up more than 5% after the company reported higher Q1 non-GAAP earnings and revenue, and raised its 2026 outlook.Merck (MRK) stock was down more than 1% after the company said it swung to a Q1 adjusted loss.Alnylam Pharmaceuticals (ALNY) shares were up more than 2% after the company posted higher Q1 adjusted net income and revenue.